Montpellier University obtains new funding thanks to its NANOREMEDI project
TheFunctional Nano-Scaffolds for Regenerative Medicine Functional Nano-Scaffolds for Regenerative Medicine, also known as NANOREMEDI, led by Gilles Subra, professor at the Faculty of Pharmacy, and Cécile Echalier, lecturer and researcher specializing in chemistry in biomaterials at the IBMM, with the participation of Danièle Noël's team at the IRMB, has secured as part of the Marie Skłodowska-Curie Actions Doctoral Network, €565,000 in funding for the training and research of doctoral students at the University of Montpellier.
The NANOREMEDI project in a nutshell
NANOREMEDI, which officially launched on September1, 2022, for a period of four years, is a Marie Skłodowska-Curie Actions Doctoral Network project led by a consortium of six universities in Europe. The main objective is to train 13 doctoral researchers the field of peptides and nanomaterials. Each of them will be jointly supervised by two universities and will spend most of their time at the university that recruits them, nine months at the second university, and three months at an industrial partner. In addition, these doctoral researchers from cross-disciplinary and interdisciplinary training and will participate in international workshops organized by NANOREMEDI partners. The University of Montpellier will therefore recruit two for this joint supervision project with the University of Milan (Italy) and IC Nanogune (San Sebastian, Spain) and will receive two others for a period of nine months each, also under joint supervision with the University of Milan and the University of Jerusalem.
From a scientific perspective, the project aims to improve human health by addressing three major challenges:
- The engineering of vascular grafts to replace damaged arteries,
- The development of stem cell-based biotherapies for bone and cartilage repair,
- Developing strategies to promote implant integration and prevent bacterial contamination.
Funding for the IBM and IRMB at the University of Montpellier
Alongside the University of Montpellier, five other universities: University of Milano (Department of Pharmaceutical Sciences), Universitat Politècnica de Catalunya (Barcelona Tech Department of Chemical Engineering), The Hebrew University Jerusalem (Institute of Chemistry), University of Pavia (Department of Drug Sciences), IC NANOGUNE (“Self-Assembly” Group, – San Sebastian) as well as 11 industrial partners, including two French companies (Lynxter and Genepep), are leading this NANOREMEDI project, which has received total funding of €3.4 million.
As such, UM receives €565,000. This provides IBMM and IRMB with the means to finance consumables and equipment to support theses and organize workshops. This same Marie Skłodowska-Curie Actions Doctoral Network funding enables doctoral programs to be rolled out in partnership with universities and companies from different sectors across Europe in order to train highly qualified doctoral students, stimulate their creativity, strengthen their capacity for innovation, and ensure their long-term employability in Europe.
Practical information:
The NANOREMEDI project in detail: https://www.nanoremedi.eu/